Confluence in technologic advances in medical electronics, the availability of new intravenous pharmaceuticals, increasing sophistication of home care delivery systems and the economic motivations imposed by Diagnosis-Related Groups and capitated care payment mechanisms stimulated dramatic developments in intravenous delivery technologies, both for the hospital and the outpatient environment. Success in the use of these sophisticated drug delivery systems, however, depends on appropriate patient selection, optimal selection of a delivery alternative and careful patient monitoring for both desired therapeutic response, health delivery quality and patient safety.
医学电子技术的进步、新型静脉用药物的可获得性、家庭护理输送系统日益复杂,以及诊断相关分组和按人头付费机制带来的经济动机,推动了静脉给药技术在医院和门诊环境中的显著发展。然而,要成功使用这些复杂的药物输送系统,取决于合适的患者选择、最佳的输送方式选择,以及对患者进行仔细监测,以确保获得预期的治疗反应、医疗服务质量和患者安全。